Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01882803
Title A Phase 2 Study of IPI-145 in Subjects With Refractory Indolent Non-Hodgkin Lymphoma (DYNAMO)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Infinity Pharmaceuticals, Inc.
Indications

non-Hodgkin lymphoma

Therapies

Duvelisib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL

Facility Status City State Zip Country Details
Los Angeles California 90095-6984 United States Details
Whittier California 90603 United States Details
Denver Colorado 80218 United States Details
Fort Myers Florida 39916 United States Details
Saint Petersburg Florida 33705 United States Details
Tallahassee Florida 32308 United States Details
Atlanta Georgia 30322 United States Details
Chicago Illinois 60637 United States Details
Louisville Kentucky 40207 United States Details
Baltimore Maryland 21204 United States Details
Baltimore Maryland 21229 United States Details
Boston Massachusetts 02215 United States Details
Saint Louis Missouri 63110 United States Details
Howell New Jersey 07731 United States Details
Morristown New Jersey 07962 United States Details
New York New York 10021 United States Details
Rockville Centre New York 11510 United States Details
Canton Ohio 44718 United States Details
Lawton Oklahoma 73505 United States Details
Oklahoma City Oklahoma 73104 United States Details
Philadelphia Pennsylvania 01911 United States Details
Nashville Tennessee 37203 United States Details
Dallas Texas 75246 United States Details
Lynchburg Virginia 24501 United States Details
Lesnoy Minsk Region 223040 Belarus Details
Brest 224027 Belarus Details
Minsk 220013 Belarus Details
Vitebsk 210603 Belarus Details
Gent 9000 Belgium Details
Kortrijk 8500 Belgium Details
Sofia 1233 Bulgaria Details
Sofia 1407 Bulgaria Details
Sofia 1431 Bulgaria Details
Sofia 1756 Bulgaria Details
Toronto Ontario M5G 2M9 Canada Details
Gatineau Quebec J8P7H2 Canada Details
Montreal Quebec H3T 1E2 Canada Details
Brno 625-00 Czechia Details
Ostrava-Poruba 708-52 Czechia Details
Angers Cedex 09 49933 France Details
Bordeaux 33076 France Details
Clermont-Ferrand 63000 France Details
Marseille 13005 France Details
Pierre Benite 69495 France Details
Tbilisi 0186 Georgia Details
Budapest 1083 Hungary Details
Budapest 1122 Hungary Details
Debrecen 4032 Hungary Details
Bologna 40138 Italy Details
Brescia 25123 Italy Details
Busto Arsizio 21052 Italy Details
Genova 16132 Italy Details
Meldola 47014 Italy Details
Milano 20162 Italy Details
Modena 41124 Italy Details
Orbassano 10043 Italy Details
Parma 43100 Italy Details
Ravenna 48121 Italy Details
Rimini 47923 Italy Details
Varese 21100 Italy Details
Barcelona 08036 Spain Details
Madrid 28222 Spain Details
Salamanca 37007 Spain Details
Cardiff CF 14 4XW United Kingdom Details
Chelsea United Kingdom Details
Liverpool L7 8XP United Kingdom Details
London NW1 2PG United Kingdom Details
London W1G 6AD United Kingdom Details
Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field